Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimization of heart rate lowering therapy in hospitalized patients with heart failure: Insights from the Optimize Heart Failure Care Program.
Lopatin YM, Cowie MR, Grebennikova AA, Sisakian HS, Pagava ZM, Hayrapetyan HG, Abdullaev TA, Voronkov LG, Chesnikova AI, Tseluyko VI, Tarlovskaya EI, Dadashova GM, Berkinbaev SF, Glezer MG, Koziolova NA, Rakisheva AG, Kipiani ZV, Kurlyanskaya AK. Lopatin YM, et al. Among authors: kipiani zv. Int J Cardiol. 2018 Jun 1;260:113-117. doi: 10.1016/j.ijcard.2017.12.093. Int J Cardiol. 2018. PMID: 29622423 Free article.
The Heart Failure Association Atlas: rationale, objectives, and methods.
Seferović PM, Jankowska E, Coats AJS, Maggioni AP, Lopatin Y, Milinković I, Polovina M, Lainščak M, Timmis A, Huculeci R, Vardas P; Task Force of the HFA Atlas, and the ESC Atlas of Cardiology leadership, developed in collaboration with the National Heart Failure Societies of the ESC member and ESC affiliated member countries. Seferović PM, et al. Eur J Heart Fail. 2020 Apr;22(4):638-645. doi: 10.1002/ejhf.1768. Epub 2020 Mar 3. Eur J Heart Fail. 2020. PMID: 32125085 Free article.
The Heart Failure Association Atlas: Heart Failure Epidemiology and Management Statistics 2019.
Seferović PM, Vardas P, Jankowska EA, Maggioni AP, Timmis A, Milinković I, Polovina M, Gale CP, Lund LH, Lopatin Y, Lainscak M, Savarese G, Huculeci R, Kazakiewicz D, Coats AJS; National Heart Failure Societies of the ESC member countries (see Appendix). Seferović PM, et al. Eur J Heart Fail. 2021 Jun;23(6):906-914. doi: 10.1002/ejhf.2143. Epub 2021 Mar 13. Eur J Heart Fail. 2021. PMID: 33634931 Free article.
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. McDonagh TA, et al. Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368. Eur Heart J. 2021. PMID: 34447992 Free article. No abstract available.
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
Spyropoulos AC, Ageno W, Albers GW, Elliott CG, Halperin JL, Hiatt WR, Maynard GA, Steg PG, Weitz JI, Suh E, Spiro TE, Barnathan ES, Raskob GE; MARINER Investigators. Spyropoulos AC, et al. N Engl J Med. 2018 Sep 20;379(12):1118-1127. doi: 10.1056/NEJMoa1805090. Epub 2018 Aug 26. N Engl J Med. 2018. PMID: 30145946 Free article. Clinical Trial.
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.
Cannon CP, Pratley R, Dagogo-Jack S, Mancuso J, Huyck S, Masiukiewicz U, Charbonnel B, Frederich R, Gallo S, Cosentino F, Shih WJ, Gantz I, Terra SG, Cherney DZI, McGuire DK; VERTIS CV Investigators. Cannon CP, et al. N Engl J Med. 2020 Oct 8;383(15):1425-1435. doi: 10.1056/NEJMoa2004967. Epub 2020 Sep 23. N Engl J Med. 2020. PMID: 32966714 Clinical Trial.
Takotsubo Syndrome: An International Expert Consensus Report on Practical Challenges and Specific Conditions (Part-1: Diagnostic and Therapeutic Challenges).
Yalta K, Madias JE, Kounis NG, Y-Hassan S, Polovina M, Altay S, Mebazaa A, Yilmaz MB, Lopatin Y, Mamas MA, Gil RJ, Thamman R, Almaghraby A, Bozkurt B, Bajraktari G, Fink T, Traykov V, Manzo-Silberman S, Mirzoyev U, Sokolovic S, Kipiani ZV, Linde C, Seferovic PM. Yalta K, et al. Among authors: kipiani zv. Balkan Med J. 2024 Oct 31;41(6):421-441. doi: 10.4274/balkanmedj.galenos.2024.2024-9-98. Epub 2024 Oct 17. Balkan Med J. 2024. PMID: 39417524 Free PMC article.
Takotsubo Syndrome: An International Expert Consensus Report on Practical Challenges and Specific Conditions (Part-2: Specific Entities, Risk Stratification and Challenges After Recovery).
Yalta K, Madias JE, Kounis NG, Y-Hassan S, Polovina M, Altay S, Mebazaa A, Yilmaz MB, Lopatin Y, Mamas MA, Gil RJ, Thamman R, Almaghraby A, Bozkurt B, Bajraktari G, Fink T, Traykov V, Manzo-Silberman S, Mirzoyev U, Sokolovic S, Kipiani ZV, Linde C, Seferovic PM. Yalta K, et al. Among authors: kipiani zv. Balkan Med J. 2024 Oct 31;41(6):442-457. doi: 10.4274/balkanmedj.galenos.2024.2024-9-99. Epub 2024 Oct 17. Balkan Med J. 2024. PMID: 39417538 Free PMC article.